Géraud Souteyrand

Géraud Souteyrand

Auto-generated profile, based on publicly available information

Géraud Souteyrand

Département de Cardiologie, CHU Clermont-Ferrand, ISIT, CaVITI, CNRS (UMR-6284), Université d′Auvergne, Clermont-Ferrand, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2016 in European Heart Journal
Verified
Journal Article
Open access
PDF file
GSGeraud Souteyrand
Geraud Souteyrand
NANicolas Amabile
Nicolas Amabile
LMLionel Mangin
Lionel Mangin
XCXavier Chabin
Xavier Chabin
NMNicolas Meneveau
Nicolas Meneveau
PMPascal Motreff
Pascal Motreff
Angiography has limited value for identifying the causes of stent thrombosis (ST). We studied a large cohort of patients by optical coherence tomography (OCT) to explore ST characteristics and mechanisms. A prospective multicentre registry was screened for patients with confirmed ST. Optical coherence tomography was performed after initial intervention to the culprit lesion (in 69% of cases in a deferred procedure). Stent thrombosis was classified as acute (AST), sub-acute (SAST), late (LST), and very late (VLST). Optical coherence tomography records were analysed in a central core lab. The analysis included 120 subjects aged 61.7 [51.4–70.7]; 89% male. Very late ST was the clinical presentation in 75%, LST in 6%, SAST in 15%, and AST in 4% of patients. Bare metal stents (BMS) were used in 39%, drug-eluting stents (DES) in 59% and bioresorbable vascular scaffolds in 2% of the cases. Optical coherence tomography identified an underlying morphological abnormality in 97% of cases, including struts malapposition (34%), neoatherosclerotic lesions (22%), major stent underexpansion (11%), coronary evagination (8%), isolated uncovered struts (8%), edge-related disease progression (8%), and neointimal hyperplasia (4%). Ruptured neoatherosclerotic lesions were more frequent with BMS than with DES (36 vs. 14%, P = 0.005), whereas coronary evaginations were more frequent with DES than with BMS (12 vs. 2%, P = 0.04). LST + VLST were mainly related to malapposition (31%) and neoatherosclerosis (28%), while prominent mechanisms for AST + SAST were malapposition (48%) and underexpansion (26%). In patients with confirmed ST, OCT imaging identified an underlying morphological abnormality in 97% of cases.

1 February 2016 in EuroIntervention
Verified
Journal Article
Open access
RGRobert-Jan M. van Geuns
Robert-Jan M. van Geuns
TYTuncay Yetgin
Tuncay Yetgin
AMAlessio La Manna
Alessio La Manna
CTCorrado Tamburino
Corrado Tamburino
GSGéraud Souteyrand
Géraud Souteyrand
WWWilliam Wyns
William Wyns
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 April 2015 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
FDFlorian Dubuisson
Florian Dubuisson
EPEmilie Péry
Emilie Péry
LOLemlih Ouchchane
Lemlih Ouchchane
NCNicolas Combaret
Nicolas Combaret
CKClaude Kauffmann
Claude Kauffmann
LSLaurent Sarry
Laurent Sarry

25 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
GSGéraud Souteyrand
Géraud Souteyrand
TMThomas Mouyen
Thomas Mouyen
BHBenjamin Honton
Benjamin Honton
AMAurélien Mulliez
Aurélien Mulliez
BLBenoit Lattuca
Benoit Lattuca
NANicolas Amabile
Nicolas Amabile
Background: Despite improvement in devices, in‐stent restenosis remains a frequent and challenging complication of percutaneous coronary interventions. Methods and Results: The RESTO (Morphological Parameters of In‐Stent Restenosis Assessed and Identified by OCT [Optical Coherence Tomography]; study NCT04268875) was a prospective multicenter registry including patients presenting with coronary syndromes related to in‐stent restenosis. All patients underwent preintervention OCT analysis, which led to analysis of in‐stent restenosis phenotype, number of strut layers, and presence of stent underexpansion. The primary end point was the in‐stent restenosis type according to the OCT morphological classification. The 1‐year incidence of target vessel failure (a composite of death from cardiac causes, target‐vessel myocardial infarction, or ischemia‐driven target‐vessel revascularization) was assessed. The study included 297 patients. The culprit stent was a drug‐eluting stent in 74.2% of cases. OCT analysis revealed the presence of neoatherosclerosis in 57% (52% calcified), neointimal hyperplasia in 43% (58% homogeneous), stent underexpansion (minimal stent area <4.5 mm 2 ) in 43%, and multiple stent layers in 30%. The prepercutaneous coronary intervention OCT analysis modified the operator's strategy for management in 30% of cases. Treatment involved drug‐eluting stent implantation in 61.6% and drug‐eluting balloon angioplasty in 36.1% of cases with only 63.2% optimal results. The 1‐year target vessel failure incidence was 11% (95% CI, 9%–13%). Residual postpercutaneous coronary intervention stent underexpansion was associated with significantly higher target vessel failure incidence (19% [95% CI, 14%–24%] versus 7% [95% CI, 5–9], P =0.01). Conclusions: OCT identified neoatherosclerosis and neointimal hyperplasia in comparable proportions. Stent underexpansion was frequent and favored subsequent adverse clinical outcomes.

20 March 2023 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
NCNicolas Combaret
Nicolas Combaret
NANicolas Amabile
Nicolas Amabile
BDBenjamin Duband
Benjamin Duband
PMPascal Motreff
Pascal Motreff
GSGéraud Souteyrand
Géraud Souteyrand
Coronary artery calcification is a complex process found predominantly in the elderly population. Coronary angiography frequently lacks sensitivity to detect, evaluate and quantify these lesions. Yet calcified lesions are considered stable, it remains associated with a higher rate of peri procedural complications during percutaneous coronary intervention (PCI) including an increased risk of stent under expansion and struts mal apposition leading to poor clinical outcome. Intracoronary imaging (Intravascular Ultra Sound (IVUS) and Optical Coherence Tomography (OCT)) allows better calcified lesions identification, localization within the coronary artery wall (superficial or deep calcifications), quantification. This lesions characterization allows a better choice of dedicated plaque-preparation tools (modified balloons, rotational or orbital atherectomy, intravascular lithotripsy) that are crucial to achieve optimal PCI results. OCT could also assess the impact of these tools on the calcified plaque morphology (plaque fracture, burring effects…). An OCT-guided tailored PCI strategy for calcified lesions still requires validation by clinical studies which are currently underway.

1 July 2017 in EuroIntervention
Verified
Journal Article
Closed access
PMPetru Mester
Petru Mester
HBHelene Bouvaist
Helene Bouvaist
NDNicolas Delarche
Nicolas Delarche
FBFrédéric Bouisset
Frédéric Bouisset
MAMohamed Abdellaoui
Mohamed Abdellaoui
LBLoic Belle
Loic Belle
The aim of this study was to ascertain whether a minimalist immediate mechanical intervention (MIMI) aiming to restore an optimal Thrombolysis In Myocardial Infarction (TIMI) flow in the culprit artery, followed ≥7 days later by a second percutaneous coronary intervention with intentional stenting, is safe in patients with ST-segment elevation myocardial infarction and large thrombotic burden. SUPER-MIMI was a prospective, observational trial conducted between January 2014 and April 2015 in 14 French centres. A total of 155 patients were enrolled. The pharmacological therapy was left to the operator's discretion. Eighty-one patients (52.3%) had glycoprotein IIb/IIIa inhibitors (GPI) initiated before the end of the first procedure. The median (interquartile range [IQR]) delay between the two procedures was eight (seven to 12) days. Infarct-related artery reocclusion between the two procedures (primary endpoint) occurred in two patients (1.3%), neither of whom received GPI treatment. TIMI flow was maintained or improved between the end of the first procedure and the beginning of the second procedure in all patients. Thrombotic burden and stenosis severity diminished significantly between the two procedures. Stents were ultimately implanted in 97 patients (62.6%). Deferred stenting (≥7 days) in patients with a high thrombus burden was safe on a background of GPI therapy.